Status | Study |
Completed |
Study Name: Thoracic Ultrasonography for Pulmonary Edema in Patients With Pre-Eclampsia Condition: Pre-eclampsia Date: 2015-01-31 Interventions: Device: Ultrasound Ultrasound of the chest for the detection of fluid in the lung |
Active, not recruiting |
Study Name: Pilot Assessment of an Automatic Blood Pressure Monitor for Diagnosis and Management of Pre-eclampsia in a Low-resource Hospital Condition: Pre Eclampsia Date: 2014-09-25 Interventions: Device: Sphygmo A team of engineers from Rice University has recently developed Sphygmo, an ambulatory, |
Recruiting |
Study Name: Phenylephrine Versus Ephedrine in Pre-eclampsia Condition: Pre-eclampsia Date: 2013-12-26 Interventions: Drug: Phenylephrine Drug: Ephedrine |
Active, not recruiting |
Study Name: Community Level Interventions for Pre-eclampsia Condition: Pre-eclampsia Hypertension, Pregnancy Induced Date: 2013-06-28 Interventions: Behavioral: Community Engagement |
Completed |
Study Name: The Effect of neutrophil-to Lymphocyte Ratio in Preeclampsia- Eclampsia Condition: Preeclampsia Eclampsia Date: 2013-05-04 Interventions: Biological: high neutrophil to lymphocyte ratio |
Completed |
Study Name: New Magnesium Sulphate Protocol for Pre-eclampsia Condition: Pre-eclampsia Date: 2013-05-01 Interventions: Drug: MgSO4 A randomized controlled study that compare three regimens for administration of MgSO4 used f |
Terminated |
Study Name: Eclampsia and Posterior Reversible Encephalopathy Syndrome (PRES): Condition: Eclampsia Date: 2013-01-15 Interventions: Drug: Dexamethasone Intravenous Dexamethasone 12 mg, 2 doses, 12 hours apart |
Completed |
Study Name: Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers Condition: Pre-eclampsia Intra-uterine Growth Restriction Date: 2012-11-02 Interventions: Drug: Aspirin Aspirin, 160 mg |
Terminated |
Study Name: Safety and Efficacy of RLX030 in Pregnant Women With Pre- Eclampsia Condition: Pre-eclampsia Date: 2012-03-27 Interventions: Drug: Placebo Placebo to RLX03 |
Completed |
Study Name: EG-VEGF : Potential Marker of Pre-eclampsia and / or Intrauterine Growth Restriction Condition: Pre-eclampsia Intra-uterine Growth Retardation Date: 2011-12-08 Interventions: Other: blood sample and doppler Ultrasound of uterine arteries |